Over the past decade, health insurance companies have increasingly embraced the use of artificial intelligence algorithms – ...

— Help teens recognize that AI companions are programmed to be agreeable and validating. Explain that’s not how real ...

Teenagers are increasingly turning to AI for advice, emotional support and decision-making, according to a new study.

Avidity Biosciences saw its share prices increase by 9.21 percent on Friday to end at $36.27 apiece as investor sentiment was bolstered by the Food and Drug Administration’s (FDA) breakthrough ...

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

Current and former members of the FDA told CNN about issues with the Elsa generative AI tool unveiled by the federal agency last month. Three employees said that in practice, Elsa has hallucinated ...

The White House has released “America’s AI Action Plan,” a national strategy to accelerate AI adoption across key sectors — with healthcare identified as a top priority for reform, innovation and ...

The FDA's 'Elsa' AI, intended to speed up drug approvals, is reportedly fabricating studies, part of a wider trend of unreliable AI in high-stakes roles.

The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.

U.S. Food and Drug Administration employees told CNN that Elsa — the AI model that’s supposed to help speed up approvals of pharmaceuticals and medical devices — isn’t working great. Instead, it cites ...

"Elsa" is supposed to speed up the process of approving drugs and medical devices. But FDA employees say the AI is creating ...

Elsa & AI Resource Center As AI becomes a core part of FDA oversight, companies who prepare now will have a distinct market advantage. This isn’t just about compliance, it’s about accelerating ...